Cargando…
Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma
Invasive lobular breast carcinoma (ILC) is the second most common breast carcinoma (BC) subtype and is mainly driven by loss of E‐cadherin expression. Correct classification of BC as ILC is important for patient treatment. This study assessed the degree of agreement among pathologists for the diagno...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822373/ https://www.ncbi.nlm.nih.gov/pubmed/34889530 http://dx.doi.org/10.1002/cjp2.253 |
_version_ | 1784646595348791296 |
---|---|
author | Christgen, Matthias Kandt, Leonie Donata Antonopoulos, Wiebke Bartels, Stephan Van Bockstal, Mieke R Bredt, Martin Brito, Maria Jose Christgen, Henriette Colpaert, Cecile Cserni, Bálint Cserni, Gábor Daemmrich, Maximilian E Danebrock, Raihanatou Dedeurwaerdere, Franceska van Deurzen, Carolien HM Erber, Ramona Fathke, Christine Feist, Henning Fiche, Maryse Gonzalez, Claudia Aura ter Hoeve, Natalie D Kooreman, Loes Krech, Till Kristiansen, Glen Kulka, Janina Laenger, Florian Lafos, Marcel Lehmann, Ulrich Martin‐Martinez, Maria Dolores Mueller, Sophie Pelz, Enrico Raap, Mieke Ravarino, Alberto Reineke‐Plaass, Tanja Schaumann, Nora Schelfhout, Anne‐Marie De Schepper, Maxim Schlue, Jerome Van de Vijver, Koen Waelput, Wim Wellmann, Axel Graeser, Monika Gluz, Oleg Kuemmel, Sherko Nitz, Ulrike Harbeck, Nadia Desmedt, Christine Floris, Giuseppe Derksen, Patrick WB van Diest, Paul J Vincent‐Salomon, Anne Kreipe, Hans |
author_facet | Christgen, Matthias Kandt, Leonie Donata Antonopoulos, Wiebke Bartels, Stephan Van Bockstal, Mieke R Bredt, Martin Brito, Maria Jose Christgen, Henriette Colpaert, Cecile Cserni, Bálint Cserni, Gábor Daemmrich, Maximilian E Danebrock, Raihanatou Dedeurwaerdere, Franceska van Deurzen, Carolien HM Erber, Ramona Fathke, Christine Feist, Henning Fiche, Maryse Gonzalez, Claudia Aura ter Hoeve, Natalie D Kooreman, Loes Krech, Till Kristiansen, Glen Kulka, Janina Laenger, Florian Lafos, Marcel Lehmann, Ulrich Martin‐Martinez, Maria Dolores Mueller, Sophie Pelz, Enrico Raap, Mieke Ravarino, Alberto Reineke‐Plaass, Tanja Schaumann, Nora Schelfhout, Anne‐Marie De Schepper, Maxim Schlue, Jerome Van de Vijver, Koen Waelput, Wim Wellmann, Axel Graeser, Monika Gluz, Oleg Kuemmel, Sherko Nitz, Ulrike Harbeck, Nadia Desmedt, Christine Floris, Giuseppe Derksen, Patrick WB van Diest, Paul J Vincent‐Salomon, Anne Kreipe, Hans |
author_sort | Christgen, Matthias |
collection | PubMed |
description | Invasive lobular breast carcinoma (ILC) is the second most common breast carcinoma (BC) subtype and is mainly driven by loss of E‐cadherin expression. Correct classification of BC as ILC is important for patient treatment. This study assessed the degree of agreement among pathologists for the diagnosis of ILC. Two sets of hormone receptor (HR)‐positive/HER2‐negative BCs were independently reviewed by participating pathologists. In set A (61 cases), participants were provided with hematoxylin/eosin (HE)‐stained sections. In set B (62 cases), participants were provided with HE‐stained sections and E‐cadherin immunohistochemistry (IHC). Tumor characteristics were balanced. Participants classified specimens as non‐lobular BC versus mixed BC versus ILC. Pairwise inter‐observer agreement and agreement with a pre‐defined reference diagnosis were determined with Cohen's kappa statistics. Subtype calls were correlated with molecular features, including CDH1/E‐cadherin mutation status. Thirty‐five pathologists completed both sets, providing 4,305 subtype calls. Pairwise inter‐observer agreement was moderate in set A (median κ = 0.58, interquartile range [IQR]: 0.48–0.66) and substantial in set B (median κ = 0.75, IQR: 0.56–0.86, p < 0.001). Agreement with the reference diagnosis was substantial in set A (median κ = 0.67, IQR: 0.57–0.75) and almost perfect in set B (median κ = 0.86, IQR: 0.73–0.93, p < 0.001). The median frequency of CDH1/E‐cadherin mutations in specimens classified as ILC was 65% in set A (IQR: 56–72%) and 73% in set B (IQR: 65–75%, p < 0.001). Cases with variable subtype calls included E‐cadherin‐positive ILCs harboring CDH1 missense mutations, and E‐cadherin‐negative ILCs with tubular elements and focal P‐cadherin expression. ILCs with trabecular growth pattern were often misclassified as non‐lobular BC in set A but not in set B. In conclusion, subtyping of BC as ILC achieves almost perfect agreement with a pre‐defined reference standard, if assessment is supported by E‐cadherin IHC. CDH1 missense mutations associated with preserved E‐cadherin protein expression, E‐ to P‐cadherin switching in ILC with tubular elements, and trabecular ILC were identified as potential sources of discordant classification. |
format | Online Article Text |
id | pubmed-8822373 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88223732022-02-11 Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma Christgen, Matthias Kandt, Leonie Donata Antonopoulos, Wiebke Bartels, Stephan Van Bockstal, Mieke R Bredt, Martin Brito, Maria Jose Christgen, Henriette Colpaert, Cecile Cserni, Bálint Cserni, Gábor Daemmrich, Maximilian E Danebrock, Raihanatou Dedeurwaerdere, Franceska van Deurzen, Carolien HM Erber, Ramona Fathke, Christine Feist, Henning Fiche, Maryse Gonzalez, Claudia Aura ter Hoeve, Natalie D Kooreman, Loes Krech, Till Kristiansen, Glen Kulka, Janina Laenger, Florian Lafos, Marcel Lehmann, Ulrich Martin‐Martinez, Maria Dolores Mueller, Sophie Pelz, Enrico Raap, Mieke Ravarino, Alberto Reineke‐Plaass, Tanja Schaumann, Nora Schelfhout, Anne‐Marie De Schepper, Maxim Schlue, Jerome Van de Vijver, Koen Waelput, Wim Wellmann, Axel Graeser, Monika Gluz, Oleg Kuemmel, Sherko Nitz, Ulrike Harbeck, Nadia Desmedt, Christine Floris, Giuseppe Derksen, Patrick WB van Diest, Paul J Vincent‐Salomon, Anne Kreipe, Hans J Pathol Clin Res Original Articles Invasive lobular breast carcinoma (ILC) is the second most common breast carcinoma (BC) subtype and is mainly driven by loss of E‐cadherin expression. Correct classification of BC as ILC is important for patient treatment. This study assessed the degree of agreement among pathologists for the diagnosis of ILC. Two sets of hormone receptor (HR)‐positive/HER2‐negative BCs were independently reviewed by participating pathologists. In set A (61 cases), participants were provided with hematoxylin/eosin (HE)‐stained sections. In set B (62 cases), participants were provided with HE‐stained sections and E‐cadherin immunohistochemistry (IHC). Tumor characteristics were balanced. Participants classified specimens as non‐lobular BC versus mixed BC versus ILC. Pairwise inter‐observer agreement and agreement with a pre‐defined reference diagnosis were determined with Cohen's kappa statistics. Subtype calls were correlated with molecular features, including CDH1/E‐cadherin mutation status. Thirty‐five pathologists completed both sets, providing 4,305 subtype calls. Pairwise inter‐observer agreement was moderate in set A (median κ = 0.58, interquartile range [IQR]: 0.48–0.66) and substantial in set B (median κ = 0.75, IQR: 0.56–0.86, p < 0.001). Agreement with the reference diagnosis was substantial in set A (median κ = 0.67, IQR: 0.57–0.75) and almost perfect in set B (median κ = 0.86, IQR: 0.73–0.93, p < 0.001). The median frequency of CDH1/E‐cadherin mutations in specimens classified as ILC was 65% in set A (IQR: 56–72%) and 73% in set B (IQR: 65–75%, p < 0.001). Cases with variable subtype calls included E‐cadherin‐positive ILCs harboring CDH1 missense mutations, and E‐cadherin‐negative ILCs with tubular elements and focal P‐cadherin expression. ILCs with trabecular growth pattern were often misclassified as non‐lobular BC in set A but not in set B. In conclusion, subtyping of BC as ILC achieves almost perfect agreement with a pre‐defined reference standard, if assessment is supported by E‐cadherin IHC. CDH1 missense mutations associated with preserved E‐cadherin protein expression, E‐ to P‐cadherin switching in ILC with tubular elements, and trabecular ILC were identified as potential sources of discordant classification. John Wiley & Sons, Inc. 2021-12-10 /pmc/articles/PMC8822373/ /pubmed/34889530 http://dx.doi.org/10.1002/cjp2.253 Text en © 2021 The Authors. The Journal of Pathology: Clinical Research published by The Pathological Society of Great Britain and Ireland & John Wiley & Sons, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Christgen, Matthias Kandt, Leonie Donata Antonopoulos, Wiebke Bartels, Stephan Van Bockstal, Mieke R Bredt, Martin Brito, Maria Jose Christgen, Henriette Colpaert, Cecile Cserni, Bálint Cserni, Gábor Daemmrich, Maximilian E Danebrock, Raihanatou Dedeurwaerdere, Franceska van Deurzen, Carolien HM Erber, Ramona Fathke, Christine Feist, Henning Fiche, Maryse Gonzalez, Claudia Aura ter Hoeve, Natalie D Kooreman, Loes Krech, Till Kristiansen, Glen Kulka, Janina Laenger, Florian Lafos, Marcel Lehmann, Ulrich Martin‐Martinez, Maria Dolores Mueller, Sophie Pelz, Enrico Raap, Mieke Ravarino, Alberto Reineke‐Plaass, Tanja Schaumann, Nora Schelfhout, Anne‐Marie De Schepper, Maxim Schlue, Jerome Van de Vijver, Koen Waelput, Wim Wellmann, Axel Graeser, Monika Gluz, Oleg Kuemmel, Sherko Nitz, Ulrike Harbeck, Nadia Desmedt, Christine Floris, Giuseppe Derksen, Patrick WB van Diest, Paul J Vincent‐Salomon, Anne Kreipe, Hans Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma |
title | Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma |
title_full | Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma |
title_fullStr | Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma |
title_full_unstemmed | Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma |
title_short | Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma |
title_sort | inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822373/ https://www.ncbi.nlm.nih.gov/pubmed/34889530 http://dx.doi.org/10.1002/cjp2.253 |
work_keys_str_mv | AT christgenmatthias interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT kandtleoniedonata interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT antonopouloswiebke interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT bartelsstephan interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT vanbockstalmieker interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT bredtmartin interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT britomariajose interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT christgenhenriette interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT colpaertcecile interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT csernibalint interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT csernigabor interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT daemmrichmaximiliane interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT danebrockraihanatou interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT dedeurwaerderefranceska interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT vandeurzencarolienhm interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT erberramona interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT fathkechristine interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT feisthenning interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT fichemaryse interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT gonzalezclaudiaaura interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT terhoevenatalied interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT kooremanloes interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT krechtill interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT kristiansenglen interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT kulkajanina interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT laengerflorian interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT lafosmarcel interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT lehmannulrich interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT martinmartinezmariadolores interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT muellersophie interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT pelzenrico interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT raapmieke interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT ravarinoalberto interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT reinekeplaasstanja interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT schaumannnora interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT schelfhoutannemarie interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT descheppermaxim interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT schluejerome interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT vandevijverkoen interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT waelputwim interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT wellmannaxel interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT graesermonika interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT gluzoleg interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT kuemmelsherko interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT nitzulrike interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT harbecknadia interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT desmedtchristine interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT florisgiuseppe interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT derksenpatrickwb interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT vandiestpaulj interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT vincentsalomonanne interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma AT kreipehans interobserveragreementforthehistologicaldiagnosisofinvasivelobularbreastcarcinoma |